The Global Shoulder Arthroplasty Market size is expected to reach $1.9 billion by 2024, rising at a market growth of 7.6% CAGR during the forecast period.
The growth of the global shoulder arthroplasty market is driven due to factors such as increasing incidences of arthritis-associated disorders such as osteoarthritis and rheumatoid arthritis, and growing geriatric population. Also, significant adoption of reverse shoulder arthroplasty by surgeons and growing sports-related injuries have further contributed to the growth of the market. Nevertheless, postoperative complications associated with shoulder arthroplasties and the cost associated with the shoulder arthroplasty devices is the factors that would limit the growth of the market. The shoulder arthroplasty market is segmented based on procedures, devices, indications, end users, and regions.

Based on Device, the market is segmented into Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems. Based on Procedure, the market is segmented into Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, and Revision Shoulder Arthroplasty. Based on Indication, the market is segmented into Fracture/Dislocation, Arthritis, Rotator Cuff Tear Arthropathy, Hill Sachs Defect, and Other Indication. Based on End User, the market is segmented into Hospitals & Clinics, and Outpatient Surgical Centers. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Wright Medical Group, Inc. /Tornier Inc., Integra Lifesciences Corporation, Zimmer Biomet, Johnson & Johnson, Smith & Nephew Plc., Arthrex, Inc., Conmed Corporation, Djo Global, Stryker Corporation, and Exactech, Inc.